Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients

The clinical outcome of heterogeneous bladder cancer (BCa) is impacted by varying molecular characteristics and clinical features, and new molecular classification is necessary to recognize patients with dichotomized prognosis. We enrolled a total of 568 BCa patients from the TCGA-BLCA and GSE13507...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Hongbing, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009041/
https://www.ncbi.nlm.nih.gov/pubmed/35433683
http://dx.doi.org/10.3389/fcell.2022.725024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009041/
https://www.ncbi.nlm.nih.gov/pubmed/35433683
http://dx.doi.org/10.3389/fcell.2022.725024

Ejemplares similares